PDCD1 and cancer: Prediction of the efficacy of PD-1 through microbial signals may require combining RNA sequencing, metabolomics, cancer process management, and intestinal fungal/viral analysis through clinical trials to fully understand the relationship between microbiota and the efficacy of tumor immunotherapy [70, 71].